In this work, we found that (1) intra-tumoral delivery of AAV-IL-27 also induced PD-L1 in T cells in peripheral lymphoid organs and tumors, and (2) AAV-IL-27 and anti-PD-1 showed synergy in inhibiting tumor growth (Figure 5). This evidence concerns the gene CD274 and neoplasm.